About Us
Overview
Our Leadership
Milestones
Group Companies
Zuventus
Gennova
Tillomed
Marcan
Mantra
Emcutix
Science & Innovation
Overview
Formulations
APIs
Biologics
Manufacturing
Investors
Media Centre
CSR
Career
Life At Emcure
Learning & Growth
Current Openings
Contact Us
About Us
Overview
Our Leadership
Milestones
Group Companies
Zuventus
Gennova
Tillomed
Marcan
Mantra
Emcutix
Science & Innovation
Overview
Formulations
APIs
Biologics
Manufacturing
Investors
Media Centre
CSR
Career
Life At Emcure
Learning & Growth
Current Openings
Contact Us
other-information-categorie: Disclosures under Regulation 30
Offer a wide range of services to help businesses establish.
Home
Disclosures under Regulation 30
20 June, 2025
Intimation under Regulation 30 – Incorporation of wholly-owned Subsidiary – Emcure Lifesciences Private Limited 17.06.2025.
Read More
20 June, 2025
Allotment of Equity Shares pursuant to exercise of ESOP under Emcure Employee Stock Option Scheme 2013 – 12.06.2025
Read More
20 June, 2025
Resignation of Senior Management Personnel – Mr. Kothiyal
Read More
20 June, 2025
Intimation under Regulation 30 – Acquisition Gujarat
Read More
20 June, 2025
Audio recording of Earnings call – Q4 FY 25
Read More
20 June, 2025
Re-appointment of Dr. Mukund Gurjar as a Whole-time Director of the Company
Read More
20 June, 2025
Appointment of Secretarial Auditor of the Company for five years
Read More
20 June, 2025
Proposed Incorporation of Wholly-owned Subsidiary – 22.05.2025
Read More
20 June, 2025
Outcome of Board Meeting & Financial Results Q4 FY25
Read More
20 June, 2025
Update on USFDA inspection at API manufacturing facility located at Kurkumbh, Pune, Maharashtra, India – 18.04.2025
Read More
Prev
«
01
02
03
04
»
Next
